Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (461-470 of 525) with videos related to

Pageof 53
Sort By:
Journal of Imaging Informatics in Medicine|April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate CancerYang Li, Maliha R Imami, Linmei Zhao, et al.
The Journal of Clinical Investigation|November 21, 2018
Peptide-based PET quantifies target engagement of PD-L1 therapeuticsDhiraj Kumar, Ala Lisok, Elyes Dahmane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Journal of Huntington'S Disease|September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative PhenotypeMichal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.
Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imagingNisi Zhang, Jai Woong Seo, Elise Robinson, et al.
EJNMMI Research|September 29, 2022
First-in-human use of <sup>11</sup>C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptorJennifer M Coughlin, Yong Du, Wojciech G Lesniak, et al.
Frontiers in Oncology|September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinomaRajan Singh, Anand K Thotakura, Suresh Alati, et al.
Annals of Nuclear Medicine|March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imagingSara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Pageof 53

Showing results (461-470 of 525) with videos related to

Sort By:
Pageof 53
Journal of Imaging Informatics in Medicine|April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate CancerYang Li, Maliha R Imami, Linmei Zhao, et al.
The Journal of Clinical Investigation|November 21, 2018
Peptide-based PET quantifies target engagement of PD-L1 therapeuticsDhiraj Kumar, Ala Lisok, Elyes Dahmane, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Journal of Huntington'S Disease|September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative PhenotypeMichal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.
Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imagingNisi Zhang, Jai Woong Seo, Elise Robinson, et al.
EJNMMI Research|September 29, 2022
First-in-human use of <sup>11</sup>C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptorJennifer M Coughlin, Yong Du, Wojciech G Lesniak, et al.
Frontiers in Oncology|September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinomaRajan Singh, Anand K Thotakura, Suresh Alati, et al.
Annals of Nuclear Medicine|March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imagingSara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
Pageof 53